{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:28:57Z","timestamp":1775863737962,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["RO1AR059794"],"award-info":[{"award-number":["RO1AR059794"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00586-017-5149-9","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T09:58:26Z","timestamp":1495706306000},"page":"2763-2772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Oxy133, an osteogenic oxysterol, on new bone formation in rat two-level posterolateral fusion model"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-0643","authenticated-orcid":false,"given":"Zorica","family":"Buser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Drapeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Stappenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata C.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Parhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"issue":"24","key":"5149_CR1","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1097\/00007632-199512150-00003","volume":"20","author":"SD Boden","year":"1995","unstructured":"Boden SD, Schimandle JH, Hutton WC, Chen MI (1995) Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part I: biology of spinal fusion. Spine 20(24):2626\u20132632","journal-title":"Spine"},{"issue":"23","key":"5149_CR2","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2106\/JBJS.J.01513","volume":"93","author":"C Myeroff","year":"2011","unstructured":"Myeroff C, Archdeacon M (2011) Autogenous bone graft: donor sites and techniques. J Bone Jt Surg Am 93(23):2227\u20132236. doi: 10.2106\/JBJS.J.01513","journal-title":"J Bone Jt Surg Am"},{"issue":"4","key":"5149_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cpm.2005.07.004","volume":"22","author":"SM Rush","year":"2005","unstructured":"Rush SM (2005) Bone graft substitutes: osteobiologics. Clin Podiatr Med Surg 22(4):619\u2013630 (viii)","journal-title":"Clin Podiatr Med Surg"},{"issue":"9","key":"5149_CR4","first-page":"406","volume":"35","author":"ST Yoon","year":"2006","unstructured":"Yoon ST (2006) Advances in osteobiologics in spine surgery. Am J Orthop (Belle Mead NJ) 35(9):406\u2013410","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"12","key":"5149_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1097\/00007632-199309000-00011","volume":"18","author":"SR Frenkel","year":"1993","unstructured":"Frenkel SR, Moskovich R, Spivak J, Zhang ZH, Prewett AB (1993) Demineralized bone matrix. Enhancement of spinal fusion. Spine (Phila Pa 1976) 18(12):1634\u20131639","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"5149_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00007632-199801150-00003","volume":"23","author":"MA Morone","year":"1998","unstructured":"Morone MA, Boden SD (1998) Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine 23(2):159\u2013167","journal-title":"Spine"},{"issue":"8","key":"5149_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00586-006-0282-x","volume":"16","author":"JC Wang","year":"2007","unstructured":"Wang JC, Alanay A, Mark D, Kanim LE, Campbell PA, Dawson EG et al (2007) A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J 16(8):1233\u20131240","journal-title":"Eur Spine J"},{"issue":"5","key":"5149_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","volume":"15","author":"JK Burkus","year":"2002","unstructured":"Burkus JK, Gornet MF, Dickman CA, Zdeblick TA (2002) Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15(5):337\u2013349","journal-title":"J Spinal Disord Tech"},{"issue":"19","key":"5149_CR9","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/BRS.0b013e3181ecf6e4","volume":"35","author":"KL Ong","year":"2010","unstructured":"Ong KL, Villarraga ML, Lau E, Carreon LY, Kurtz SM, Glassman SD (2010) Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976) 35(19):1794\u20131800","journal-title":"Spine (Phila Pa 1976)"},{"key":"5149_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","volume":"158","author":"R Fu","year":"2013","unstructured":"Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M (2013) Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med 158:890\u2013902","journal-title":"Ann Intern Med"},{"key":"5149_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7326\/0003-4819-158-12-201306180-00005","volume":"158","author":"MC Simmonds","year":"2013","unstructured":"Simmonds MC, Brown JV, Heirs MK, Higgins JP, Mannion RJ, Rodgers MA, Stewart LA (2013) Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med 158:877\u2013889","journal-title":"Ann Intern Med"},{"issue":"6","key":"5149_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.drudis.2014.01.012","volume":"19","author":"CT Laurencin","year":"2014","unstructured":"Laurencin CT, Ashe KM, Henry N, Kan HM, Lo KW (2014) Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications. Drug Discov Today 19(6):794\u2013800. doi: 10.1016\/j.drudis.2014.01.012","journal-title":"Drug Discov Today"},{"issue":"1","key":"5149_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.2000.80.1.361","volume":"80","author":"GJ Schroepfer Jr","year":"2000","unstructured":"Schroepfer GJ Jr (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80(1):361\u2013554","journal-title":"Physiol Rev"},{"issue":"5","key":"5149_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1359\/jbmr.040115","volume":"19","author":"HT Kha","year":"2004","unstructured":"Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F (2004) Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner Res 19(5):830\u2013840","journal-title":"J Bone Miner Res"},{"key":"5149_CR15","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/jcb.23082","volume":"112","author":"JS Johnson","year":"2011","unstructured":"Johnson JS, Meliton V, Kim WK, Lee KB, Wang JC, Nguyen K, Yoo D, Jung ME, Atti E, Tetradis S, Pereira RC, Magyar C, Nargizyan T, Hahn TJ, Farouz F, Thies S, Parhami F (2011) Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo. J Cell Biochem 112:1673\u20131684","journal-title":"J Cell Biochem"},{"issue":"8","key":"5149_CR16","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/jbmr.2213","volume":"29","author":"SR Montgomery","year":"2014","unstructured":"Montgomery SR, Nargizyan T, Meliton V, Nachtergaele S, Rohatgi R, Stappenbeck F, Jung ME, Johnson JS, Aghdasi B, Tian H, Weintraub G, Inoue H, Atti E, Tetradis S, Pereira RC, Hokugo A, Alobaidaan R, Tan Y, Hahn TJ, Wang JC, Parhami F (2014) A novel osteogenic oxysterol compound for therapeutic development to promote bone growth: activation of hedgehog signaling and osteogenesis through smoothened binding. J Bone Miner Res 29(8):1872\u20131885","journal-title":"J Bone Miner Res"},{"issue":"4","key":"5149_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.spinee.2014.11.014","volume":"15","author":"TP Scott","year":"2015","unstructured":"Scott TP, Phan KH, Tian H, Suzuki A, Montgomery SR, Johnson JS, Atti E, Tetratis S, Pereira RC, Wang JC, Daubs MD, Stappenbeck F, Parhami F (2015) Comparison of a novel oxysterol molecule and rhBMP2 fusion rates in a rabbit posterolateral lumbar spine model. Spine J 15(4):733\u2013742","journal-title":"Spine J"},{"key":"5149_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/term.2047","author":"A Li","year":"2015","unstructured":"Li A, Hokugo A, Segovia LA, Yalom A, Rezzadeh K, Zhou S, Zhang Z, Parhami F, Stappenbeck F, Jarrahy R (2015) Oxy133, a novel osteogenic agent, promotes bone regeneration in an intramembranous bone-healing model. J Tissue Eng Regen Med. doi: 10.1002\/term.2047","journal-title":"J Tissue Eng Regen Med"},{"key":"5149_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00003086-196807000-00007","volume":"59","author":"AF DePalma","year":"1968","unstructured":"DePalma AF, Rothman RH (1968) The nature of pseudarthrosis. Clin Orthop Relat Res 59:113\u2013118","journal-title":"Clin Orthop Relat Res"},{"key":"5149_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00003086-199211000-00011","volume":"284","author":"JC Steinmann","year":"1992","unstructured":"Steinmann JC, Herkowitz HN (1992) Pseudarthrosis of the spine. Clin Orthop Relat Res 284:80\u201390","journal-title":"Clin Orthop Relat Res"},{"issue":"suppl 3","key":"5149_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00586-015-3929-7","volume":"24","author":"P Berjano","year":"2015","unstructured":"Berjano P, Langella F, Damilano M, Pejrona M, Buric J, Ismael M, Villafa\u00f1e JH, Lamartina C (2015) Fusion rate following extreme lateral lumbar interbody fusion. Eur Spine J 24(suppl 3):369\u2013371","journal-title":"Eur Spine J"},{"issue":"4","key":"5149_CR22","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2015.7.FOCUS15292","volume":"39","author":"DS Chun","year":"2015","unstructured":"Chun DS, Baker KC, Hsu WK (2015) Lumbar pseudarthrosis: a review of current diagnosis and treatment. Neurosurg Focus 39(4):E10","journal-title":"Neurosurg Focus"},{"key":"5149_CR23","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/00007632-199520120-00002","volume":"20","author":"JH Schimandle","year":"1995","unstructured":"Schimandle JH, Boden S, Hutton WC (1995) Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20:1326\u20131337","journal-title":"Spine"},{"key":"5149_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","volume":"31","author":"LBE Shields","year":"2006","unstructured":"Shields LBE, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB (2006) Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31:542\u2013547","journal-title":"Spine"},{"key":"5149_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/ten.tea.2010.0555","volume":"17","author":"JN Zara","year":"2011","unstructured":"Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Li W, Chiang M, Chung J, Kwak J, Wu BM, Ting K, Soo C (2011) High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17:1389\u20131399","journal-title":"Tissue Eng Part A"},{"key":"5149_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.spinee.2006.12.006","volume":"8","author":"GR Buttermann","year":"2008","unstructured":"Buttermann GR (2008) Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac crest autograft in anterior cervical discectomy and fusion. Spine J 8:426\u2013435","journal-title":"Spine J"},{"key":"5149_CR27","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1097\/BRS.0b013e3181d81ef2","volume":"35","author":"TE Mroz","year":"2010","unstructured":"Mroz TE, Wang JC, Hashimoto R, Norvell DC (2010) Complications related to osteobiologics use in spine surgery: a systematic review. Spine 35:S86\u2013S104","journal-title":"Spine"},{"issue":"8","key":"5149_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","volume":"5","author":"I Takada","year":"2009","unstructured":"Takada I, Kouzmenko AP, Kato S (2009) Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5(8):442\u2013447","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"5149_CR29","first-page":"656","volume":"18","author":"I Takada","year":"2008","unstructured":"Takada I, Kato S (2008) Molecular mechanism of switching adipocyte\/osteoblast differentiation through regulation of PPAR-gamma function. Clin Calcium 18(5):656\u2013661","journal-title":"Clin Calcium"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00586-017-5149-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-017-5149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-017-5149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:47:01Z","timestamp":1692816421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00586-017-5149-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["5149"],"URL":"https:\/\/doi.org\/10.1007\/s00586-017-5149-9","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"assertion":[{"value":"22 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declared that they have no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Financial activities outside of submitted work (forms were submitted during submission) as: ZB- consultancy: Xenco Medical, consultancy: AO Spine (past); SD \u2013 salaried employee during completion of work and manuscript, also stocks and option; no longer employed by Medtronic; FS-MAXBioPharma employee and stocks\/options; RP \u2013 nothing to disclose; FP \u2013 Founder, President and Board Member of MAX BioPharma, patents and stocks option MAX BioPharma; JCW \u2013 Royalties: Aesculap, Biomet, Amedica, Seaspine, Synthes, Stock Ownership: Fziomed, Private Investments: Promethean Spine, Paradigm spine, Benevenue, NexGen, Vertiflex, electrocore, surgitech, expanding orthopaedics, osprey, bone biologics, curative biosciences, pearldiver, Board of Directors: North American Spine Society (non-financial, reimbursement for travel for board meetings, courses, etc.), North American Spine Foundation (non-financial), Cervical Spine Research Society (non-financial, reimbursement for travel for board meetings), AO Spine\/AO Foundation (honorariums for board position), Fellowship Support: AO Foundation (spine fellowship funding paid to institution).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}